Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,093 | 180 | 99.9% |
| Education | $2.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $514.41 | 20 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $424.56 | 27 | $0 (2024) |
| Egalet US Inc | $350.20 | 32 | $0 (2018) |
| Medtronic, Inc. | $326.60 | 9 | $0 (2024) |
| Medtronic USA, Inc. | $300.44 | 15 | $0 (2020) |
| Purdue Pharma L.P. | $218.26 | 11 | $0 (2017) |
| Daiichi Sankyo Inc. | $191.82 | 15 | $0 (2019) |
| PFIZER INC. | $116.39 | 8 | $0 (2019) |
| Pernix Therapeutics Holdings, Inc. | $93.79 | 6 | $0 (2018) |
| Kaleo, Inc. | $92.20 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $238.64 | 6 | Medtronic, Inc. ($167.00) |
| 2023 | $307.67 | 17 | Collegium Pharmaceutical, Inc. ($174.44) |
| 2022 | $47.91 | 3 | Medtronic, Inc. ($25.43) |
| 2021 | $92.97 | 5 | Medtronic, Inc. ($48.64) |
| 2020 | $74.53 | 4 | Nevro Corp. ($26.41) |
| 2019 | $326.00 | 18 | Abbott Laboratories ($79.40) |
| 2018 | $603.49 | 36 | Abbott Laboratories ($168.05) |
| 2017 | $1,404 | 92 | Egalet US Inc ($289.79) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $154.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 08/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Neuromodulation | ||||||
| 04/17/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Endocrinology | ||||||
| 01/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Opioid Analgesic | ||||||
| 12/14/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Opioid Analgesic | ||||||
| 11/15/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.56 | General |
| Category: Opioid Analgesic | ||||||
| 09/21/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.79 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.65 | General |
| Category: Opioid Analgesic | ||||||
| 07/12/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.91 | General |
| Category: Opioid Analgesic | ||||||
| 07/12/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $1.39 | General |
| Category: Opioid Analgesic | ||||||
| 06/27/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Opioid Analgesic | ||||||
| 06/21/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $6.93 | General |
| Category: Opioid Analgesic | ||||||
| 06/21/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $1.01 | General |
| Category: Opioid Analgesic | ||||||
| 06/20/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROLOGY | ||||||
| 06/01/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $6.76 | General |
| Category: Opioid Analgesic | ||||||
| 05/16/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Opioid Analgesic | ||||||
| 05/15/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $24.63 | General |
| Category: non-opioid analgesic | ||||||
| 03/16/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Opioid Analgesic | ||||||
| 02/12/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $55.93 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/09/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Opioid Analgesic | ||||||
| 01/16/2023 | Medtronic, Inc. | PILLCAM (Device) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Capsule Endoscopy | ||||||
| 09/23/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Pain Management | ||||||
| 02/23/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,906 | 6,734 | $869,662 | $287,371 |
| 2022 | 23 | 1,852 | 6,579 | $827,094 | $278,567 |
| 2021 | 23 | 1,616 | 4,812 | $687,245 | $244,993 |
| 2020 | 26 | 1,975 | 5,835 | $738,418 | $263,610 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 91 | 148 | $143,336 | $50,534 | 35.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 117 | 203 | $132,441 | $35,523 | 26.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 143 | 175 | $99,750 | $32,933 | 33.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 85 | 137 | $53,682 | $25,735 | 47.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 91 | 116 | $66,564 | $22,683 | 34.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 104 | 132 | $71,370 | $20,046 | 28.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 103 | 173 | $59,000 | $16,113 | 27.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 115 | 153 | $39,592 | $13,417 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 115 | $26,450 | $10,983 | 41.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 86 | 111 | $27,104 | $9,982 | 36.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 39 | 50 | $28,800 | $9,883 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 128 | $19,840 | $7,984 | 40.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 84 | 113 | $19,320 | $5,686 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $16,836 | $5,676 | 33.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 20 | 33 | $14,256 | $4,672 | 32.8% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 12 | 13 | $12,389 | $4,048 | 32.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 14 | $5,992 | $2,677 | 44.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 45 | 63 | $7,245 | $2,433 | 33.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 18 | 30 | $6,450 | $2,183 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,544 | $1,922 | 34.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 198 | 1,318 | $6,590 | $1,127 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $1,843 | $803.33 | 43.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 270 | 3,420 | $5,268 | $329.18 | 6.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 82 | 129 | $123,533 | $45,820 | 37.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 143 | 167 | $95,190 | $32,750 | 34.4% |
About Dr. Bhavin Suthar, MD
Dr. Bhavin Suthar, MD is a Specialist healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376574459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bhavin Suthar, MD has received a total of $3,096 in payments from pharmaceutical and medical device companies, with $238.64 received in 2024. These payments were reported across 181 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,093).
As a Medicare-enrolled provider, Suthar has provided services to 7,349 Medicare beneficiaries, totaling 23,960 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Fredericksburg, VA
- Active Since 07/06/2006
- Last Updated 05/28/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1376574459
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $248.36
- SPRIX (Drug) $202.56
- Xtampza ER (Drug) $174.25
- SCS IPGs (Device) $164.45
- HYSINGLA ER (Drug) $156.34
- Belbuca (Drug) $154.92
- VECTRIS (Device) $152.81
- OXAYDO (Drug) $147.64
- Morphabond ER (Drug) $143.06
- PISCES (Device) $105.47
- LYRICA (Drug) $103.33
- Proclaim Family of SCS IPGs (Device) $98.14
- XTAMPZA (Drug) $95.39
- ZOHYDRO ER (Drug) $93.79
- Evzio (Drug) $77.09
- SCS leads (Device) $50.81
- Movantik (Drug) $48.76
- Amitiza (Drug) $48.73
- PENNSAID (Drug) $48.55
- RESTORE (Device) $46.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fredericksburg
Dr. Jay Stauffer, Md, MD
Specialist — Payments: $16,526
Piper Brock, Do, DO
Specialist — Payments: $3,885
Dr. Geoffrey Sloan, Md, MD
Specialist — Payments: $3,693
Lee Brock, Md, MD
Specialist — Payments: $397.77
Ms. Paula Lauria, Msn-Crna, MSN-CRNA
Specialist — Payments: $83.68
Walter Walek, M.d, M.D
Specialist — Payments: $52.98